Answers are grounded in this paper and cite their sources.
IL-10 IFNγ-secreting CD4+ T cells are suppressive T cells able to inhibit cytotoxic T lymphocyte regulated by several signal pathways and have therapeutic implication for infectious diseases and autoimmune diseases. IL-10 IFN-γ-secreting CD4+ T cells were first found in the early 1990s. They are suppressive T cells able to inhibit cytotoxic T lymphocytes. These cells (Foxp3–T bet+) have a similar function but are distinct from conventional Tregs. The production of IL-10 in these cells requires IL-27 and TGF-β and was regulated by several signal pathways including Notch, STAT, and NF-κB. The crosstalk among these pathways is critical for the generation and function of these cells. IL-10 IFN-γ-secreting CD4+ T cells are activated in chronic infection and are responsible for prolonged infection. Thus, their modulation has therapeutic implications for the treatment of infectious diseases. However, it is complicated, and fine-tuning of IFN-γ and IL-10 secretion by these cells is needed for disease management, as inhibition of these cells will also lead to overimmune responses. On the other hand, increasing their numbers in autoimmune diseases may have beneficial effects.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: